October 5-7, 2026 | Prague
DMDG-GMP-SPS Joint Meeting 2026
The 2026 joint meeting brings together DMDG, GMP, and SPS, covering a broad cross-section of the European DMPK community.
Peregrion attends with business development and scientific staff to discuss microtracer-based ADME, metabolite work, and AMS program design.
Activities
1:1 scientific and business development meetings throughout the conference.
Attending from Peregrion
- Steven Erpelinck (Chief Commercial Officer)
- Suzanne van Gerwen (VP Business Development)
- Jelle Reijnen (Scientist)
Topics for discussion
- Design of human ADME programs around AMS microtracer doses
- Mass balance studies with reduced radioactive exposure
- Metabolite profiling and structural identification
- Selection criteria for AMS versus, or alongside, conventional 14C approaches
- Sponsor-specific case discussions with Jelle
Book a meeting with our team: info@peregrion.com.
